Olink Holding AB (publ) (OLK) Stock Price, News & Analysis

Company Overview

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Key Stats

• Today's Range: $26.08 to $26.08
• 50-Day Range: $26.08 to $26.08
• 52-Week Range: $14.10 to $26.09
• Volume: 1,000 shs
• Average Volume: 633,228 shs
• Market Capitalization: $3.24 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.00
• Consensus Rating: Hold

Olink Holding AB (publ) Stock Analysis - MarketRank™

Olink Holding AB (publ) scored higher than 1% of companies evaluated by MarketBeat, and ranked 1003rd out of 1,004 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Olink Holding AB (publ) has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Olink Holding AB (publ) has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Olink Holding AB (publ) are expected to grow in the coming year, from ($0.19) to $0.02 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Olink Holding AB (publ) is -96.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Olink Holding AB (publ) is -96.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Olink Holding AB (publ) has a P/B Ratio of 6.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for OLK.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Olink Holding AB (publ) does not currently pay a dividend.

Dividend Growth

Olink Holding AB (publ) does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for OLK.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for OLK on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Olink Holding AB (publ) insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 5.20% of the stock of Olink Holding AB (publ) is held by insiders.

Percentage Held by Institutions

Only 30.19% of the stock of Olink Holding AB (publ) is held by institutions.

OLK Stock Analysis - Frequently Asked Questions

How were Olink Holding AB (publ)'s earnings last quarter?

Olink Holding AB (publ) (NASDAQ:OLK) released its earnings results on Monday, May, 13th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The company had revenue of $28.75 million for the quarter, compared to the consensus estimate of $31.29 million. Olink Holding AB (publ) had a negative net margin of 19.72% and a negative trailing twelve-month return on equity of 7.07%.

When did Olink Holding AB (publ) IPO?

Olink Holding AB (publ) (OLK) raised $301 million in an IPO on Thursday, March 25th 2021. The company issued 17,700,000 shares at $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley and SVB Leerink served as the underwriters for the IPO and BTIG was co-manager.

What other stocks do shareholders of Olink Holding AB (publ) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Olink Holding AB (publ) investors own include MSP Recovery (LIFW), MSP Recovery (LIFW), Adobe (ADBE), Devon Energy (DVN), Silicon Motion Technology (SIMO), Teradyne (TER) and WPP (WPP).

Company Calendar

• Last Earnings: 5/13/2024
• Today: 10/13/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:OLK
• CUSIP: N/A
• CIK: 1835539
• Web: www.olink.com
• Phone: 46 (0) 18 444 39 70
• Fax: N/A
• Employees: 420
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $26.00
• High Stock Price Target: $26.00
• Low Stock Price Target: $26.00
• Potential Upside/Downside: -0.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-31,600,000.00
• Net Margins: -19.72%
• Pretax Margin: -24.84%
• Return on Equity: -7.07%
• Return on Assets: -6.05%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.60
• Quick Ratio: 3.91

Sales & Book Value

• Annual Sales: $170.89 million
• Price / Sales: 18.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.04 per share
• Price / Book: 6.46

Miscellaneous

• Outstanding Shares: 124,343,000
• Free Float: 117,877,000
• Market Cap: $3.24 billion
• Optionable: Optionable
• Beta: 0.52